The ability of a modified live canine parvovirus type 2b vaccine to elicit active immunization in pups with maternally derived antibodies (MDA) by intranasal administration was evaluated. The vaccine induced seroconversion in 100% of pups with MDA titers of <= 80 and in 51.6% of pups with titers between 160 and 320.
Immunogenicity of an intranasally administered modified live canine parvovirus type 2b vaccine in pups with maternally derived antibodies
MARTELLA, Vito;CAVALLI, Alessandra;DECARO, Nicola;ELIA, Gabriella;DESARIO, COSTANTINA;CAMPOLO, MARCO;BOZZO, GIANCARLO;TARSITANO, ELVIRA;BUONAVOGLIA, Canio
2005-01-01
Abstract
The ability of a modified live canine parvovirus type 2b vaccine to elicit active immunization in pups with maternally derived antibodies (MDA) by intranasal administration was evaluated. The vaccine induced seroconversion in 100% of pups with MDA titers of <= 80 and in 51.6% of pups with titers between 160 and 320.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
